Nobuhiko Moniwa

868 total citations
15 papers, 685 citations indexed

About

Nobuhiko Moniwa is a scholar working on Cancer Research, Genetics and Hematology. According to data from OpenAlex, Nobuhiko Moniwa has authored 15 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 5 papers in Genetics and 5 papers in Hematology. Recurrent topics in Nobuhiko Moniwa's work include Protease and Inhibitor Mechanisms (8 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Nobuhiko Moniwa is often cited by papers focused on Protease and Inhibitor Mechanisms (8 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Nobuhiko Moniwa collaborates with scholars based in Japan and Germany. Nobuhiko Moniwa's co-authors include Toshihiko Terao, Hiroshi Kobayashi, Hiromitsu Shinohara, Junko Gotoh, Kenji Takakura, Emi Morioka, Kazuhiro Sumimoto, Manami Imai, Kokichi Arisawa and H. Graeff and has published in prestigious journals such as International Journal of Cancer, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research and Thrombosis and Haemostasis.

In The Last Decade

Nobuhiko Moniwa

14 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuhiko Moniwa Japan 9 305 223 201 169 164 15 685
K Späthe Germany 8 298 1.0× 275 1.2× 242 1.2× 124 0.7× 266 1.6× 9 800
Awatif Al‐Nafussi United Kingdom 10 69 0.2× 172 0.8× 153 0.8× 145 0.9× 116 0.7× 23 505
Volker Moebus Germany 15 224 0.7× 144 0.6× 164 0.8× 56 0.3× 393 2.4× 52 705
Anil Sadarangani United States 15 270 0.9× 55 0.2× 648 3.2× 48 0.3× 183 1.1× 32 970
Ayumi Hongo Japan 17 177 0.6× 56 0.3× 508 2.5× 146 0.9× 370 2.3× 31 944
Elizabeth Masse United States 7 167 0.5× 129 0.6× 370 1.8× 16 0.1× 159 1.0× 8 625
A Harłozińska Poland 14 76 0.2× 144 0.6× 234 1.2× 35 0.2× 219 1.3× 55 587
Karen A. Cadoo United States 19 162 0.5× 247 1.1× 241 1.2× 214 1.3× 365 2.2× 74 868
Hidekazu Ohi Japan 9 334 1.1× 14 0.1× 202 1.0× 48 0.3× 176 1.1× 16 552
Clara Salamanca Canada 12 170 0.6× 290 1.3× 382 1.9× 49 0.3× 178 1.1× 15 708

Countries citing papers authored by Nobuhiko Moniwa

Since Specialization
Citations

This map shows the geographic impact of Nobuhiko Moniwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuhiko Moniwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuhiko Moniwa more than expected).

Fields of papers citing papers by Nobuhiko Moniwa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuhiko Moniwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuhiko Moniwa. The network helps show where Nobuhiko Moniwa may publish in the future.

Co-authorship network of co-authors of Nobuhiko Moniwa

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuhiko Moniwa. A scholar is included among the top collaborators of Nobuhiko Moniwa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuhiko Moniwa. Nobuhiko Moniwa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Suzuki, Nobutaka, Kazuo UEBABA, Takafumi Kohama, et al.. (2008). French maritime pine bark extract significantly lowers the requirement for analgesic medication in dysmenorrhea: a multicenter, randomized, double-blind, placebo-controlled study.. PubMed. 53(5). 338–46. 19 indexed citations
2.
Kobayashi, Hiroshi, Kazuhiro Sumimoto, Nobuhiko Moniwa, et al.. (2006). Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan. International Journal of Gynecological Cancer. 17(1). 37–43. 228 indexed citations
3.
Moniwa, Nobuhiko. (1997). Relationship of urokinase type plasminogen activator, plasminogen activator inhibitor type 1 and activated protein C in fibrinolysis of human placenta.. PubMed. 48(2). 215–20. 5 indexed citations
4.
Schmitt, Manfred, Olaf G. Wilhelm, Viktor Magdolen, et al.. (1995). Urokinase‐Type Plasminogen Activator (uPA) and Its Receptor (CD87): A New Target in Tumor Invasion and Metastasis. PubMed. 21(2). 151–165. 50 indexed citations
5.
Harbeck, Nadia, Nobuko Yamamoto, Nobuhiko Moniwa, et al.. (1995). MODEL SYSTEM FOR ISOLATION OF COMPETENT OVARIAN-CARCINOMA CELLS FROM FRESH TUMOR-TISSUE BY A MAGNETIC SEPARATION TECHNIQUE (MACS). International Journal of Oncology. 6(6). 1249–54. 8 indexed citations
6.
Kobayashi, Hiroshi, Junko Gotoh, Michio Fujie, et al.. (1994). Inhibition of metastasis of lewis lung carcinoma by a synthetic peptide within growth factor‐like domain of urokinase in the experimental and spontaneous metastasis model. International Journal of Cancer. 57(5). 727–733. 74 indexed citations
7.
Kobayashi, Hiroshi, Junko Gotoh, Hiromitsu Shinohara, Nobuhiko Moniwa, & Toshihiko Terao. (1994). Inhibition of the Metastasis of Lewis Lung Carcinoma by Antibody Against Urokinase-Type Plasminogen Activator in the Experimental and Spontaneous Metastasis Model. Thrombosis and Haemostasis. 71(4). 474–480. 49 indexed citations
8.
Moniwa, Nobuhiko, et al.. (1994). Role of activated protein C in facilitating basement membrane invasion by tumor cells.. PubMed. 54(1). 261–7. 28 indexed citations
9.
Moniwa, Nobuhiko, et al.. (1993). Effects of membrane-associated cathepsin B on the activation of receptor-bound prourokinase and subsequent invasion of reconstituted basement membranes. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1178(1). 55–62. 81 indexed citations
10.
Kobayashi, Hiroshi, Nobuhiko Moniwa, Motoi Sugimura, et al.. (1993). Increased Cell‐surface Urokinase in Advanced Ovarian Cancer. Japanese Journal of Cancer Research. 84(6). 633–640. 25 indexed citations
11.
Kobayashi, Hiroshi, Hidekazu Ohi, Nobuhiko Moniwa, Hiromitsu Shinohara, & Toshihiko Terao. (1993). Characterization of CA 125 antigen identified by monoclonal antibodies that recognize different epitopes. Clinical Biochemistry. 26(5). 391–397. 6 indexed citations
12.
Schmitt, Mark R., F. Jänicke, Nobuhiko Moniwa, et al.. (1992). Tumor-Associated Urokinase-Type Plasminogen Activator: Biological and Clinical Significance. Biological Chemistry Hoppe-Seyler. 373(2). 611–622. 105 indexed citations
13.
Schmitt, Manfred, Lothar Goretzki, Nobuhiko Moniwa, et al.. (1992). Flow cytofluorometry in tumour cell receptor analysis. Survey of the literature and recent developments concerning the urokinase-type plasminogen activator (uPA). Biochemical Society Transactions. 20(1). 208–216. 6 indexed citations
14.
Harbeck, Nadia, Nobuhiko Moniwa, Evan L. Busch, et al.. (1991). Durchflußzytometrische DNA-Analyse von reinen Zellkernen aus formalin-fixierten Paraffinschnitten beim primären Mammakarzinom: Korrelation mit anderen Prognosefaktoren. Gyn�kologisch-geburtshilfliche Rundschau. 31(Suppl. 2). 299–302.
15.
Harbeck, Nadia, Nobuhiko Moniwa, Max Schmitt, et al.. (1991). [Flow cytometry DNA analysis of pure cell nuclei from formalin fixed paraffin sections in primary breast cancer: correlation with other prognostic factors].. PubMed. 31 Suppl 2. 299–302. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K Späthe Breakdown of academic impact, for papers by Awatif Al‐Nafussi Breakdown of academic impact, for papers by Volker Moebus Breakdown of academic impact, for papers by Anil Sadarangani Breakdown of academic impact, for papers by Ayumi Hongo Breakdown of academic impact, for papers by Elizabeth Masse Breakdown of academic impact, for papers by A Harłozińska Breakdown of academic impact, for papers by Karen A. Cadoo Breakdown of academic impact, for papers by Hidekazu Ohi Breakdown of academic impact, for papers by Clara Salamanca
Rankless by CCL
2026